Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine and Mometasone Irrigation vs Sprays in Chronic Rhinitis
NCT05626621Phase 4Recruiting
- Sponsor
- Endeavor Health
- Start
- Nov 2022
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azelastine in chronic rhinitis, sponsored by Endeavor Health. Primary endpoint: Sino-Nasal Outcome Test-22 at 6 months. Started Nov 2022; status: recruiting.
02
Drugs
azelastine
03
Conditions
chronic rhinitis
Beyond the preview
Go deeper on NCT05626621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626621.